It is highly expressed in different types of cancer characterized by elevated copper levels, and high CTR‐1 expression enhances PD‐L1 expression by promoting cellular copper influx, aggravating PD‐L1‐driven tumor immune escape.51 Here, SLC31A1 is linked to neoplasm.